SMALL CELL LUNG CANCER (SCLC)
Clinical trials for SMALL CELL LUNG CANCER (SCLC) explained in plain language.
Never miss a new study
Get alerted when new SMALL CELL LUNG CANCER (SCLC) trials appear
Sign up with your email to follow new studies for SMALL CELL LUNG CANCER (SCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy trial offers hope for advanced cancer patients out of options
Disease control OngoingThis study tested an immunotherapy drug called pembrolizumab in people with many different types of advanced solid tumors that had stopped responding to standard treatments. The main goal was to see if the drug could shrink tumors and to identify biological markers that might pre…
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for Tough-to-Treat lung cancer: major trial tests promising drug
Disease control OngoingThis study is testing whether a new drug called tarlatamab helps people with small cell lung cancer live longer and feel better after their cancer has returned following initial chemotherapy. It compares tarlatamab directly against the current standard treatments. The main goal i…
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Muscle strength could predict lung cancer treatment success
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 160 lung cancer patients to understand how changes in muscle mass, strength, and function affect their ability to complete treatment, quality of life, and survival. Researchers will measure these factors during routine hospital visits without changing standard …
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Sponsor: Zealand University Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC